Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Eur J Immunol. 2012 Jun;42(6):1488–1499. doi: 10.1002/eji.201142263

Figure 3. Starting number of NP118-specific memory CD8 T-cells at the time of LCMV infection dictate secondary expansion and mortality in vaccinated PKO mice.

Figure 3

Five groups of naïve PKO mice (10 /group) received splenocytes from previously immunized donor PKO memory mice containing 8×105 or 8×104 or 8×103 or 8×102 or 0 NP118-specific memory CD8 T-cells one day before LCMV-Arm challenge .A) Phenotype of NP118-specific memory CD8 T-cells prior to adoptive transfer as detected by direct ex-vivo Ld/NP118 tetramer staining without antigen stimulation (top row) or intracellular IFN-γ after in vitro antigen stimulation (bottom row). Survival B) and morbidity measured as weight loss C) of the recipient PKO mice after LCMV-Arm infection (7 /group). D) Number of IFN-γ+ CD8+ T cells (mean + SD, n=3) in the spleen of recipient PKO mice in the absence (left panel) or presence (right panel) of NP118 peptide stimulation at day 5 post LCMV infection. Data are representative of at least 2 independent experiments.